Effect of relapse to high-risk behavior on the costs and benefits of a program to screen women for human immunodeficiency virus

Interfaces

Volumn 28, Issue 3, 1998, Pages 52-74

  Owens, Douglas K ^a,b   Brandeau, Margaret L ^b   Sox, Carol H ^c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0039403218     PISSN: 00922102     EISSN: None     Source Type: Journal    
DOI: 10.1287/inte.28.3.52     Document Type: Article

References (95)

1. Aboulker, J. P. and Swart, A. M. 1993, "Preliminary analysis of the Concorde trial," The Lancet, Vol. 341, No. 8849, pp. 889-890.
2. Adib, S.; Joseph, J.; Ostrow, D.; and James, S. 1991, "Predictors of relapse in sexual practices among homosexual men," AIDS Education and Prevention, Vol. 3, No. 4, pp. 293-304.
3. Adib, S. M.; Joseph, J. G.; Ostrow, D. G.; Tal, M.; and Schwartz, S. A. 1991, "Relapse in sexual behavior among homosexual men: A 2-year follow-up from the Chicago MACS/CCS," AIDS, Vol. 5, No. 6, pp. 757-760.
4. Aggleton, P.; O'Reilly, K.; Slutkin, G.; and Davies, P. 1994, "Risking everything? Risk behavior, behavior change, and AIDS," Science, Vol. 265, No. 5170, pp. 341-345.
5. Anderson, R. M. 1988, "The epidemiology of HIV infection: Variable incubation plus infection periods and heterogeneity in sexual activity," Journal of the Royal Statistical Society-A, Vol. 151 (Part 1), pp. 66-93.
6. Anderson, R. M. and May, R. M. 1988, "Epidemiological parameters of HIV transmission," Nature, Vol. 333, No. 6173, pp. 514-519.
7. Anderson, R. M. and Medley, G. F. 1988, "Epidemiology of HIV infection and AIDS: Incubation and infectious periods, survival and vertical transmission," AIDS, Vol. 2 (Suppl. 1), pp. S57-S63.
8. Auger, I.; Thomas, P.; deGruttola, V.; Morse, D.; Moore, D.; Williams, R.; Truman, B.; and Lawrence, C. E. 1988, "Incubation periods for paediatric AIDS patients (letter)," Nature, Vol. 336, No. 6199, pp. 575-577.
9. Bailey, N. T. J. 1975, The Mathematical Theory of Infectious Diseases and Its Applications, Hafner Press, New York.
10. Bandura, A. 1994, "Social cognitive theory and exercise of control over HIV infection," in Preventing AIDS: Theories and Methods of Behavioral Interventions, eds. R. J. DiClemente and J. Peterson, Plenum Publishing, New York, pp. 25-59.
11. Barbacci, M.; Repke, J. T.; and Chaisson, R. E. 1991, "Routine prenatal screening for HIV infection," The Lancet, Vol. 337, No. 8743, pp. 709-711.
12. Blanche, S.; Rouzioux, C.; Moscato, M. L. G.; Veber, F.; Mayaux, N-J.; Jacomet, C.; Tricoire, J.; Deville, A.; Vial, M.; Firtion, G.; de Crepy, A.; Douard, D.; Robin, M.; Courpotin, C.; Ciraru-Vigneron, N.; le Diest, F.; Griscelli, C.; and the HIV Infection in Newborns French Collaborative Study Group 1989, "A prospective study of infants born to women seropositive for human immunodeficiency virus type 1," New England Journal of Medicine, Vol. 320, No. 25, pp. 1643-1648.
13. Bloom, D. E. and Carliner, G. 1988, "The economic impact of AIDS in the United States," Science, Vol. 239, No. 4840, pp. 604-639.
14. Bowie, C. and Ford, N. 1989, "Sexual behavior of young people and the risk of HIV infection," Journal of Epidemiology and Community Health, Vol. 43, No. 1, pp. 61-65.
15. Brandeau, M. L.; Lee, H. L.; Owens, D. K.; Sox, C. H.; and Wachter, R. M. 1990, "Policy analysis of human immunodeficiency virus screening and intervention: A review of modeling approaches," AIDS and Public Policy Journal, Vol. 5, No. 3, pp. 119-131.
16. Brandeau, M. L.; Lee, H. L.; Owens, D. K.; Sox, C. H.; and Wachter, R. M. 1991, "Modeling human immunodeficiency virus screening and intervention: Analysis of screening policies to reduce HIV transmission to newborns," Interfaces, Vol. 21, No. 3, pp. 5-25.
17. Brandeau, M. L. and Owens, D. K. 1994, "When women return to risk: Costs and benefits of HIV screening in the presence of relapse," in Modeling the AIDS Epidemic: Planning, Policy and Prediction, eds. E. Kaplan and M. L. Brandeau, Raven Press, New York, pp. 121-136.
18. Brandeau, M. L.; Owens, D. K.; Sox, C. H.; and Wachter, R. M. 1992, "Screening women of childbearing age for human immunodeficiency virus: A cost-benefit analysis," Archives of Internal Medicine, Vol. 152, No. 11, pp. 2229-2237.
19. Brandeau, M. L.; Owens, D. K.; Sox, C. H.; and Wachter, R. M. 1993, "Screening women of childbearing age for human immunodeficiency virus infection: A model-based policy analysis," Management Science, Vol. 39, No. 1, pp. 72-92.
20. California Department of Finance Population Research Unit 1988, "Projected total population for California by race/ethnicity," Report No. 88P-4, State of California, Sacramento, California, February.
21. California Department of Health Services Health and Welfare Agency 1987, Vital Statistics of California 1985, State of California, Sacramento, California.
22. California Department of Health Services Office of AIDS 1988, "AIDS-related knowledge, attitudes, beliefs and behavior among California adults: A population-based assessment of baseline levels," California AIDS Update, Vol. 1, No. 1, pp. 14-21.
23. Calsyn, D. A.; Saxon, A. J.; Freeman, G., Jr.; and Whittaker, S. 1992, "Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users," American Journal of Public Health, Vol. 82, No. 4, pp. 573-575.
24. Centers for Disease Control 1988, "Number of sex partners and potential risk of sexual exposure to human immunodeficiency virus," Morbidity and Mortality Weekly Report, Vol. 37, No. 37, pp. 566-568.
25. Centers for Disease Control 1990, "Update: Serologic testing for HIV-1 antibody - United States, 1988 and 1989," Morbidity and Mortality Weekly Report, Vol. 39, No. 22, pp. 380-383.
26. Centers for Disease Control 1991, "Patterns of sexual behavior change among homosexual/bisexual men - Selected U.S. sites, 1987-1990," Morbidity and Mortality Weekly Report, Vol. 40, No. 46, pp. 792-794.
27. Collier, A. C.; Coombs, R. W.; Schoenfeld, D.A.; Bassett, R. L.; Timpone, J.; Baruch, A.; Jones, M.; Facey, K.; Whitacre, C.; and McAuliffe, V. J. 1996, "Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine," New England Journal of Medicine, Vol. 334, No. 16, pp. 1011-1017.
28. Connell, R. W. 1987, Gender and Power, Stanford University Press, Stanford, California.
29. Connor, E. M.; Sperling, R. S.; Gelber, R.; Kiselev, P.; Scott, G.; O'Sullivan, M. J.; VanDyke, R.; Bey, M.; Shearer, W.; and Jacobsen, R. L. 1994, "Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group," New England Journal of Medicine, Vol. 331, No. 18, pp. 1173-1180.
30. D'Aquila, R. T.; Hughes, M. D.; Johnson, V. A.; Fischl, M. A.; Sommadossi, J. P.; Liou, S. H.; Timpone, J.; Myers, M.; Basgoz, N.; and Niu, M. 1996, "Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial," Annals of Internal Medicine, Vol. 124, No. 12, pp. 1019-1030.
31. Davis, S. F.; Byers, R. H.; Lindegren, M. L.; Caldwell, B.; Karon, J. M.; and Gwinn, M. 1995, "Prevalence and incidence of vertically acquired HIV infection in the United States," Journal of the American Medical Association, Vol. 247, No. 12, pp. 952-955.
32. DiClemente, R. J. and Wingood, G. M. 1995, "A randomized controlled trial of an HIV sexual risk-reduction intervention for young African-American women," Journal of the American Medical Association, Vol. 274, No. 16, pp. 1271-1276.
33. El-Bassel, N. and Schilling, R. F. 1992, "15-month followup of women methadone patients taught skills to reduce heterosexual HIV transmission," Public Health Reports, Vol. 107, No. 5, pp. 500-504.
34. El-Sadr, W.; Oleske, J. M.; Agins, B. D.; Bauman, K. A.; Brosgart, C. L.; Brown, G. M.; Geaga, J. V.; Greenspan, D.; Hein, K.; Holzemer, W. L.; Jackson, R. E.; Lindsay, M.K.; Makadon, H. J.; Moon, M. W.; Rappoport, C. A.; Scott, G.; Shervington, W. W.; Shulman, L. C.; and Wofsy, C. B. 1994, "Evaluation and management of early HIV infection. Clinical Practice Guideline No. 7," Report No. 94-0572, Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, Rockville, Maryland, January.
35. Elkstrand, M. L. and Coates, T. J. 1990, "Maintenance of safer sexual behavior and predictors of risky sex: The San Francisco Men's Health Study," American Journal of Public Health, Vol. 80, No. 8, pp. 973-977.
36. Enthoven, A. C. and Wilson, N. A. 1990, "Health-care financing and technology assessment," in Medical Informatics: Computer Applications in Medical Care, eds. E. H. Shortliffe and L. E. Perreault, Addison-Wesley, Menlo Park, California, pp. 585-619.
37. European Collaborative Study 1988, "Mother-to-child transmission of HIV infection," The Lancet, Vol. 331, No. 8619, pp. 1039-1043.
38. Fischl, M. A.; Richman, D. D.; and Hansen, N. 1990, "The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection," Annals of Internal Medicine, Vol. 112, No. 10, pp. 727-737.
39. Fuchs, V. R. and Perreault, L. 1986, "Expenditures for reproduction-related health care," Journal of the American Medical Association, Vol. 255, No. 1, pp. 76-81.
40. Gallant, J.; Moore, R.; and Chaisson, R. 1994, "Prophylaxis for opportunistic infections in patients with HIV infection," Annals of Internal Medicine, Vol. 120, No. 11, pp. 932-944.
41. Graham, N. M.; Zeger, S. L.; Park, L. P.; Phair, J. P.; Detels, R.; Vermund, S. H.; Ho, M.; and Saah, A. J. 1991, "Effect of zidovudine and pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS," The Lancet, Vol. 338, No. 8762, pp. 265-269.
42. Graham, N. M. H.; Zeger, S. L.; Park, L. P.; and Phair, J. P. 1992, "The effects on survival of early treatment of human immunodeficiency virus infection," New England Journal of Medicine, Vol. 326, No. 16, pp. 1037-1042.
43. Gwinn, M.; Pappaioanou, M.; George, J. R.; Hannon, W. H.; Wasser, S. C.; Redus, M. A.; Hoff, R.; Grady, G. F.; Willoughby, A.; and Novello, A. C. 1991, "Prevalence of HIV infection in childbearing women in the United States," Journal of the American Medical Association, Vol. 265, No. 13, pp. 1704-1708.
44. Hahn, B. and Lefkowitz, D. 1992, Annual Expenses and Sources of Payment for Health Care Services, Agency for Health Care Policy and Research, Rockville, Maryland.
45. Hamilton, J. D.; Hartigan, P. M.; Simberkoff, M.S.; Day, P. L.; Diamond, G. R.; Dickinson, G.M.; Drusano, G. L.; Egorin, M. J.; George, W.L.; and Gordin, F. M. 1992, "A controlled trial of early versus late treatment with zidovodine in symptomatic human immunodeficiency syndrome infection," New England Journal of Medicine, Vol. 326, No. 7, pp. 437-443.
46. Hardy, W. D.; Feinberg, J.; Finkelstein, D. M.; Power, M. E.; He, W.; Kaczka, C.; Frame, P.T.; Holmes, M.; Waskin, H.; and Fass, R. J. 1992, "A controlled trial of trimethoprimsulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome," New England Journal of Medicine, Vol. 327, No. 26, pp. 1842-1848.
47. Hardy, A. M.; Rauch, K.; Echenberg, D.; Morgan, W. M.; and Curran, J. W. 1986, "The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States," Journal of the American Medical Association, Vol. 255, No. 2, pp. 209-211.
48. Hedlund, K.; Spencer, J.; Schalla, W.; Johnson, L.; and Fehd, R. 1990, "Estimated public costs of HIV counseling and testing," Proceedings and Abstracts of the Sixth International Conference on AIDS, June 20-24, 1990, University of California, San Francisco, California, Vol. 2, p. 290.
49. Hegarty, J. D.; Abrams, E. J.; Hutchinson, V. E.; Nicholas, S. W.; Suarez, M. S.; and Heagarty, M. C. 1988, "The medical care costs of human immunodeficiency virus-infected children in Harlem," Journal of the American Medical Association, Vol. 260, No. 13, pp. 1901-1905.
50. Hellinger, F. 1992, "Forecasts of the costs of medical care for persons with HIV: 1992-1995," Inquiry, Vol. 29, No. 3, pp. 356-365.
51. Higgins, D. L.; Galavotti, C.; O'Reilly, K. R.; Schnell, D. J.; Moore, M.; Rugg, D. L.; and Johnson, R. 1991, "Evidence for the effects of HIV antibody counseling and testing on risk behaviors," Journal of the American Medical Association, Vol. 266, No. 17, pp. 2419-2429.
52. Ickovics, J. R.; Morrill, A. C.; Beren, S. E.; Walsh, U.; and Rodin, J. 1994, "Limited effects of HIV counseling and testing for women," Journal of the American Medical Association, Vol. 272, No. 6, pp. 443-448.
53. Institutes of Medicine 1988, Confronting AIDS: Update 1988, National Academy Press, Washington, D.C.
54. Jewett, J. F. and Hecht, F. M. 1993, "Preventive health care for adults with HIV infection," Journal of the American Medical Association, Vol. 269, No. 9, pp. 1144-1153.
55. Kamenga, M. 1989, "Condom use and associated HIV seroconversion following intensive HIV counseling of 122 married couples in Zaire with discordant HIV serology," Proceedings and Abstracts of the Fifth International Conference on AIDS, Montreal, June 4-9, 1989, International Development Research Centre, Health and Welfare Canada, and the World Health Organization, Ottawa, Ontario, Vol. 1, p. 703.
56. Kaplan, E. H. and Abramson, P. R. 1989, "So what if the program ain't perfect? A mathematical model of AIDS education," Evaluation Review, Vol. 13, No. 2, pp. 107-122.
57. Kippax, S.; Crawford, J.; Davis, M.; Roddan, P.; and Dowsett, G. 1993, "Sustaining safe sex: A longitudinal study of a sample of homosexual men," AIDS, Vol. 7, No. 2, pp. 257-263.
58. Ku, L. C.; Sonenstein, F. L.; and Pleck, J. H. 1992, "The association of AIDS education and sex education with sexual behavior and condom use among teenage men," Family Planning Perspectives, Vol. 24, No. 3, pp. 100-106.
59. Landefeld, C. S.; Chren, M. M.; Shega, J.; Speroff, T.; and McGuire, E. 1988, "Students' sexual behavior, knowledge, and attitudes relating to the acquired immunodeficiency syndrome," Journal of General Internal Medicine, Vol. 3, No. 2, pp. 161-165.
60. Landesman, S. H.; Kalish, L. A.; Burns, D. N.; Minkoff, H.; Fox, H. E.; Zorilla, C.; Garcia, P.; Fowler, M. G.; Mofenson, L.; and Tuomala, R. 1996, "Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study," New England Journal of Medicine, Vol. 334, No. 25, pp. 1617-1623.
61. Lindan, C. 1990, "HIV testing and education promote safer sex among urban women in Rwanda.," Proceedings and Abstracts of the Sixth International Conference on AIDS, June 20-24, 1990, University of California, San Francisco, California, Vol. 3, p. 256.
62. Longini, I. M.; Clark, W. S.; Byers, R. H.; Ward, J. W.; Darrow, W. W.; Lemp, G. F.; and Hethcote, H. W. 1989, "Statistical analysis of the stages of HIV infection using a Markov model," Statistics in Medicine, Vol. 8, No. 7, pp. 831-843.
63. Lundgren, J. D.; Phillips, A. N.; Pedersen, C.; Clumeck, N.; Gatell, J. M.; Johnson, A. M.; Ledergerber, B.; Vella, S.; and Nielson, J. O. 1994, "Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine," Journal of the American Medical Association, Vol. 271, No. 14, pp. 1088-1092.
64. MacDonald, K. L.; Jackson, J. B.; Bowman, R. J.; Polesky, H. F.; Rhame, F. S.; Balfour, H. H.; and Osterholm, M. T. 1989, "Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors," Annals of Internal Medicine, Vol. 110, No. 7, pp. 617-621.
65. Masur, H. 1992, "Prevention and treatment of pneumocystis pneumonia," New England Journal of Medicine, Vol. 327, No. 26, pp. 1853-1860.
66. McCusker, J.; Stoddard, A. M.; Mayer, K. H.; Japka, J.; Morrison, C.; and Saltzman, S. P. 1988, "Effects of HIV antibody test knowledge on subsequent sexual behaviors in a cohort of homosexually active men," American Journal of Public Health, Vol. 78, No. 4, pp. 462-167.
67. McCusker, J.; Stoddard, A. M.; McDonald, M.; Zapka, J. G.; and Mayer, K. H. 1992, "Maintenance of behavioral change in a cohort of homosexually active men," AIDS, Vol. 6, No. 8, pp. 861-868.
68. Miike, L. 1987, "AIDS antibody testing," in Hearing before the Subcommittee on Regulation and Business Opportunities of the Committee on Small Business, House of Representatives, U.S. Government Printing Office, Washington, DC., Serial No. 100-32, pp. 41-75.
69. Murphy, D. L. 1987, "Heterosexual contacts of intravenous drug abusers: Implications for the next spread of the AIDS epidemic," Advances in Alcohol and Substance Abuse, Vol. 7, No. 2, pp. 89-97.
70. National Center for Health Statistics. 1987, Vital Statistics of the United States, 1987, Life Tables, Public Health Service, Washington, DC.
71. O'Campo, P.; DeBoer, M. A.; Faden, R. R.; Gielen, A. C.; Kass, N.; and Chaisson, R. 1992, "Discrepancies between women's personal interview data and medical record documentation of illicit drug use, sexually transmitted diseases, and HIV infection," Medical Care, Vol. 30, No. 10, pp. 965-971.
72. Osmond, D.; Charlebois, E.; Lang, W.; Shiboski, S.; and Moss, A. 1994, "Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983-1993," Journal of the American Medical Association, Vol. 271, No. 14, pp. 1083-1087.
73. Owens, D. K. forthcoming, "Economic evaluations of HIV screening," in Handbook of HIV Prevention Policy Analysis, ed. D. R. Holtgrave, Plenum, New York.
74. Owens, D. K.; Cardinalli, A. B.; and Nease, R. F., Jr. 1997, "Physicians' assessments of the utility of health states associated with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infection," Quality of Life Research, Vol. 6, No. 1. pp. 77-86.
75. Owens, D. K.; Harris, R. A.; Scott, P. M.; and Nease, R. F. 1995, "Screening surgeons for HIV infection: A cost-effectiveness analysis," Annals of Internal Medicine, Vol. 122, No. 9, pp. 641-652.
76. Owens, D. K.; Nease, R. F.; and Harris, R. A. 1996, "Cost-effectiveness of HIV screening in acute care settings," Archives of Internal Medicine, Vol. 156, No. 4, pp. 394-404.
77. Peckham, C. and Gibb, D. 1995, "Mother-to-child transmission of the human immunodeficiency virus," New England Journal of Medicine, Vol. 33, No. 5, pp. 298-302.
78. Schapiro, J. M.; Winters, M. A.; Stewart, F.; Efron, B.; Norris, J.; Kozal, M. J.; and Merigan, T. C. 1996, "The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients," Annals of Internal Medicine, Vol. 124, No. 12, pp. 1039-1050.
79. Schneider, M. M.; Hoepelman, A. I.; Eeftinck Schattenkerk, J. K.; Nielsen, T. L.; van der Graaf, Y.; Frissen, J. P.; van der Ende, I. M.; Kolsters, A. F.; and Borleffs, J. C. 1992, "A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection," New England Journal of Medicine, Vol. 327, No. 26, pp. 1836-1841.
80. Schoenbaum, E. E.; Hartel, D.; Selwyn, P. A.; Klein, R. S.; Davenny, K.; Rogers, M.; Feiner, C.; and Friedland, G. 1989, "Risk factors for human immunodeficiency virus infection in intravenous drug users," New England Journal of Medicine, Vol. 321, No. 13, pp. 874-879.
81. Schwartz, J. S.; Kinosian, B. P.; Pierskalla, W. P.; and Lee, H. L. 1990, "Strategies for screening blood for HIV antibody," Journal of the American Medical Association, Vol. 264, No. 13, pp. 1704-1710.
82. Scitovsky, A. A. and Rice, D. P. 1987, "Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States: 1985, 1986 and 1991," Public Health Reports, Vol. 102, No. 1, pp. 5-17.
83. Scott, G. B. 1989, "Perinatal HIV-1 infection: Diagnosis and management," Clinical Obstetrics and Gynecology, Vol. 32, No. 3, pp. 477-484.
84. Selwyn, P. A.; Carter, R. J.; Schoenbaum, E. E.; Robertson, V. J.; Klein, R. S.; and Rogers, M. F. 1989, "Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users," Journal of the American Medical Association, Vol. 261, No. 24, pp. 3567-3571.
85. Sonenstein, F. L.; Pleck, J. H.; and Ku, L. C. 1989, "Sexual activity, condom use and AIDS awareness among adolescent males," Family Planning Perspectives, Vol. 21, No. 4, pp. 152-158.
86. Stall, R.; Ekstrand, M.; Pollack, L.; McKusick, L.; and Coates, T. J. 1990, "Relapse from safer sex: The next challenge for AIDS prevention efforts," Journal of Acquired Immune Deficiency Syndromes, Vol. 3, No. 12, pp. 1181-1187.
87. Usher, D. 1985, "The value of life for decision making in the public sector," Social Philosophy and Policy, Vol. 2, No. 2, pp. 168-191.
88. Valdiserri, R. O.; Lyter, D.; Leviton, L. C.; Callahan, C. M.; Kingsley, L. A.; and Rinaldo, C. R. 1988, "Variables influencing condom use in a cohort of gay and bisexual men," American Journal of Public Health, Vol. 78, No. 7, pp. 801-805.
89. van Druten, H. A. M.; van Griensven, F. J. P.; and Hendriks, J. C. M. 1994, "Homosexual role behavior and the spread of HIV," in Modeling the AIDS Epidemic: Planning, Policy, and Prediction, eds. E. Kaplan and M. L. Brandeau, Raven Press, New York, pp. 515-532.
90. Volberding, P. A.; Legakos, S. W.; Koch, M. A.; Pettinelli, C.; Myers, M. W.; Booth, D. K.; Balfour, H. H., Jr.; Reichman, R. C.; Bartlett, J. A.; and Hirsch, M. S. 1990, "Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter," New England Journal of Medicine, Vol. 322, No. 14, pp. 941-949.
91. Wasser, S. C.; Aral, S. O.; Reed, D. S.; and Bowen, G. S. 1989, "Assessing behavioral risk for HIV infection in family-planning and STD clinics," Sexually Transmitted Diseases, Vol. 16, No. 4, pp. 178-183.
92. Wenger, N. S.; Greenberg, J. M.; Hilborne, L. H.; Kusseling, F.; Mangotich, M.; and Shapiro, M. F. 1992, "Effect of HIV antibody testing and AIDS education on communication about HIV risk and sexual behavior: A randomized, controlled trial in college students," Annals of Internal Medicine, Vol. 117, No. 11, pp. 905-911.
93. Wenger, N. S.; Linn, L. S.; Epstein, M.; and Shapiro, M. F. 1991, "Reduction of high-risk sexual behavior among heterosexuals undergoing HIV antibody testing: A randomized clinical trial," American Journal of Public Health, Vol. 81, No. 12, pp. 1580-1585.
94. Wiley, J. A.; Herschkorn, S. J.; and Padian, N. S. 1989, "Heterogeneity in the probability of HIV transmission per sexual contact: The case of male-to-female transmission in penile-vaginal intercourse," Statistics in Medicine, Vol. 8, No. 1, pp. 93-102.
95. Working Group on HIV Testing of Pregnant Women and Newborns 1990, "HIV infection, pregnant women, and newborns," Journal of the American Medical Association, Vol. 264, No. 18, pp. 2416-2420.